Policy number: SRP 038
Policy name: Continuous Positive Airway Pressure (CPAP) in adults
Status: Group Prior Approval
Effective date: 1 April 2024
Next review date: 1 April 2026
Mid and South Essex ICB commissions Continuous Positive Airway Pressure (CPAP) on a restrictive basis for patients with moderate or severe Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) in adults (≥15 apnoea/hypopnoea events/hour).
CPAP is the first-choice therapy for patients with moderate or severe OSAHS that is sufficiently symptomatic to require intervention.
Persistent low CPAP use (less than two hours per night) over six months, following efforts to improve patient comfort, should lead to a review of treatment.
Funding for patients not meeting the above criteria will only be granted in clinically exceptional circumstances.
Find out more information on applying for funding in exceptional clinical circumstances
References: